BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6111350)

  • 41. Quantitation and regulation of pyroglutamyl peptidase II messenger RNA levels in rat tissues and GH3 cells.
    Lin J; Wilk S
    Neuroendocrinology; 1998 Mar; 67(3):197-208. PubMed ID: 9630437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of pyroglutamyl peptidase II synthesis by phorbol ester in the Y-79 retinoblastoma cell.
    Suen CS; Wilk S
    Endocrinology; 1991 Apr; 128(4):2169-74. PubMed ID: 1672274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancement of the thermal stability of pyroglutamyl peptidase I by introduction of an intersubunit disulfide bond.
    Kabashima T; Li Y; Kanada N; Ito K; Yoshimoto T
    Biochim Biophys Acta; 2001 Jun; 1547(2):214-20. PubMed ID: 11410277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purification of and kinetic studies on a narrow specificity synaptosomal membrane pyroglutamate aminopeptidase from guinea-pig brain.
    O'Connor B; O'Cuinn G
    Eur J Biochem; 1985 Jul; 150(1):47-52. PubMed ID: 2862039
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acyl-peptide hydrolase from rat liver. Characterization of enzyme reaction.
    Kobayashi K; Smith JA
    J Biol Chem; 1987 Aug; 262(24):11435-45. PubMed ID: 3305492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolism of thyrotropin-releasing hormone in human cerebrospinal fluid. Isolation and characterization of pyroglutamate aminopeptidase activity.
    Prasad C; Jayaraman A
    Brain Res; 1986 Feb; 364(2):331-7. PubMed ID: 2868782
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of subtilisin BPN' with peptide chloromethyl ketones.
    Powers JC; Lively MO; Tippett JT
    Biochim Biophys Acta; 1977 Jan; 480(1):246-61. PubMed ID: 831835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Purification of a specific inhibitor of pyroglutamyl aminopeptidase II from the marine annelide Hermodice carunculata. in vivo effects in rodent brain.
    Pascual I; Gil-Parrado S; Cisneros M; Joseph-Bravo P; Díaz J; Possani LD; Charli JL; Chávez M
    Int J Biochem Cell Biol; 2004 Jan; 36(1):138-52. PubMed ID: 14592539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The interaction of trifluoroacetyl peptide chloromethyl ketones with porcine pancreatic elastase. Direct evidence for nonproductive enzyme.inhibitor complexes.
    Dimicoli JL; Renaud A; Lestienne P; Bieth JG
    J Biol Chem; 1979 Jun; 254(12):5208-18. PubMed ID: 447642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative analysis of pyroglutamic acid in peptides.
    Suzuki Y; Motoi H; Sato K
    J Agric Food Chem; 1999 Aug; 47(8):3248-51. PubMed ID: 10552639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The substrate specificity of pyrrolidone carboxylyl peptidase from Bacillus amyloliquefaciens.
    Fujiwara K; Kobayashi R; Tsuru D
    Biochim Biophys Acta; 1979 Sep; 570(1):140-8. PubMed ID: 39608
    [No Abstract]   [Full Text] [Related]  

  • 52. Presence of a particulate thyrotropin-releasing hormone-degrading pyroglutamate aminopeptidase activity in rat liver.
    Scharfmann R; Morgat JL; Aratan-Spire S
    Neuroendocrinology; 1989 Apr; 49(4):442-8. PubMed ID: 2566131
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis of N alpha-[3H]acetyl-L-lysine chloromethyl ketone and its use in the fluorographic detection of proteases.
    Nishikata M
    Anal Biochem; 1993 Oct; 214(1):222-6. PubMed ID: 8250226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A technique for the removal of pyroglutamic acid from the amino terminus of proteins using calf liver pyroglutamate amino peptidase.
    Podell DN; Abraham GN
    Biochem Biophys Res Commun; 1978 Mar; 81(1):176-85. PubMed ID: 26343
    [No Abstract]   [Full Text] [Related]  

  • 55. Zymogen/enzyme discrimination using peptide chloromethyl ketones.
    Williams EB; Krishnaswamy S; Mann KG
    J Biol Chem; 1989 May; 264(13):7536-45. PubMed ID: 2708377
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antitumor agents: diazomethyl ketone and chloromethyl ketone analogues prepared from N-tosyl amino acids.
    Sajadi Z; Kashani M; Loeffler LJ; Hall IH
    J Med Chem; 1980 Mar; 23(3):275-8. PubMed ID: 7365742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Benarthin: a new inhibitor of pyroglutamyl peptidase. III. Synthesis and structure-activity relationships.
    Hatsu M; Tuda M; Muraoka Y; Aoyagi T; Takeuchi T
    J Antibiot (Tokyo); 1992 Jul; 45(7):1088-95. PubMed ID: 1355473
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pyroglutamyl N-termini of thermal polyamino acids.
    Melius P; Hubbard WL
    Biosystems; 1987; 20(3):213-7. PubMed ID: 2887217
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The development of two fluorimetric assays for the determination of pyroglutamyl aminopeptidase type-II activity.
    Gallagher SP; O'Leary RM; O'Connor B
    Anal Biochem; 1997 Jul; 250(1):1-9. PubMed ID: 9234892
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chloroketone hydrolysis by chymotrypsin and N-methylhistidyl-57-chymotrypsin: implications for the mechanism of chymotrypsin inactivation by chloroketones.
    Prorok M; Albeck A; Foxman BM; Abeles RH
    Biochemistry; 1994 Aug; 33(32):9784-90. PubMed ID: 8068658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.